SCHEMBL7789347

SCHEMBL7789347

COc1ccc2c(c1)-c1cccc(OC)c1C2=NO

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.57
KMT2A Q03164 5/20 0.57
MAPT P10636 4/20 0.57
ALDH1A1 P00352 1/20 0.57
APP P05067 1/20 0.57
SNCA P37840 1/20 0.57
CYP1A2 P05177 3/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
CYP1A1 P04798 2/20 0.44
CYP1B1 Q16678 2/20 0.44
CYP2E1 P05181 1/20 0.44
CYP2C8 P10632 1/20 0.44
CYP2A6 P11509 1/20 0.44
CYP4B1 P13584 1/20 0.44
CYP2B6 P20813 1/20 0.44
CYP3A5 P20815 1/20 0.44
CYP2A7 P20853 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7789346 1.00 MEN1 (0.57) MEN1KMT2AMAPTALDH1A1APP
SCHEMBL27740829 0.84 CYP1A2 (0.55) MEN1KMT2AMAPTALDH1A1APP
SCHEMBL7786952 0.81 KMT2A (0.85) MEN1KMT2AMAPTALDH1A1APP
SCHEMBL28191369 0.79 CYP1A2 (0.53) MEN1KMT2AMAPTALDH1A1APP
SCHEMBL7786267 0.77 MAPT (0.56) MEN1KMT2AMAPTALDH1A1CYP1A2
SCHEMBL7781778 0.74 CYP3A4 (0.44) MEN1KMT2AMAPTALDH1A1CYP1A2
SCHEMBL7781779 0.74 CYP3A4 (0.44) MEN1KMT2AMAPTALDH1A1CYP1A2
SCHEMBL7792409 0.72 MEN1 (0.57) MEN1KMT2AMAPTALDH1A1CYP1A2
SCHEMBL7792661 0.71 MEN1 (0.55) MEN1KMT2AMAPTALDH1A1CYP1A2
SCHEMBL11271335 0.70 EGFR (0.56) MEN1KMT2AMAPTALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1088855-C Oximesulfonic acid esters and use thereof as latent sulfonic acids CIBA SC HOLDING AG (CH) 2002-08-07 CN disclosed
US-20010037037-A1 Oximesulfonic acid esters and the use thereof as latent sulfonic acids CIBA SPEICIALTY CHEMICALS CORP. 2001-11-01 US disclosed
US-6017675-A POLYMERIZATION CATALYST CIBA SPECIALTY CHEMIALS CORPORATION (US) 2000-01-25 US disclosed
CN-1153926-A Oximesulfonic acid esters and use thereof as latent sulfonic acids CIBA GEIGY AG (CH) 1997-07-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010037037-A1 Oximesulfonic acid esters and the use thereof as latent sulfonic acids QSOX1, HAO2, PAH MEN1 4038/4885KMT2A 2207/4885MAPT 4475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.